Table E: GAAP to non-GAAP reconciling items: Nine Months Ended Q3 2018 |
|
|
||||||||||||||
|
|
Cost of revenues |
|
Research and
|
|
Selling, general
|
|
Interest and other
|
||||||||
GAAP [i] |
|
$ |
1,173,121 |
|
|
$ |
281,617 |
|
|
$ |
262,940 |
|
|
$ |
(58,229 |
) |
[1] Stock-based compensation |
|
12,689 |
|
|
28,720 |
|
|
35,152 |
|
|
— |
|
||||
[2] Changes in value of deferred compensation plan |
|
299 |
|
|
1,406 |
|
|
1,690 |
|
|
(2,497 |
) |
||||
[3] Equity in gain/loss, net of equity method investee |
|
— |
|
|
— |
|
|
— |
|
|
10,873 |
|
||||
[4] Imputed interest on convertible debt, equity component amortization on convertible debt and others |
|
— |
|
|
— |
|
|
— |
|
|
14,628 |
|
||||
[5] Loss on extinguishment of Spansion convertible notes and debt issuance cost write off due to refinancing |
|
— |
|
|
— |
|
|
— |
|
|
3,258 |
|
||||
[6] Amortization of debt issuance costs |
|
— |
|
|
— |
|
|
— |
|
|
1,073 |
|
||||
[7] Amortization of acquisition-related intangible assets and others |
|
150,441 |
|
|
— |
|
|
13,815 |
|
|
— |
|
||||
[8] Gain on sale of cost method investment |
|
— |
|
|
— |
|
|
(1,521 |
) |
|
— |
|
||||
[9] Acquisition costs |
|
— |
|
|
— |
|
|
119 |
|
|
— |
|
||||
[10] Restructuring charges and other |
|
3,136 |
|
|
841 |
|
|
11,347 |
|
|
— |
|
||||
[11] Litigation settlement and other |
|
— |
|
|
— |
|
|
(605 |
) |
|
(1,270 |
) |
||||
Non - GAAP [ii] |
|
$ |
1,006,556 |
|
|
$ |
250,650 |
|
|
$ |
202,943 |
|
|
$ |
(32,164 |
) |
Impact of reconciling items [ii - i] |
|
$ |
(166,565 |
) |
|
$ |
(30,967 |
) |
|
$ |
(59,997 |
) |
|
$ |
26,065 |
|
Table F: Non-GAAP gross profit |
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
Q3'19 |
|
Q2'19 |
|
Q3'18 |
|
Q3'19 |
|
Q3'18 |
||||||||||
GAAP gross profit |
|
$ |
216,441 |
|
|
$ |
198,758 |
|
|
$ |
259,715 |
|
|
$ |
617,608 |
|
|
$ |
706,245 |
|
Impact of reconciling items on cost of revenues (see Table A, B, C, D and E) |
|
52,917 |
|
|
51,258 |
|
|
56,481 |
|
|
157,514 |
|
|
166,565 |
|
|||||
Non-GAAP gross profit |
|
$ |
269,358 |
|
|
$ |
250,016 |
|
|
$ |
316,196 |
|
|
$ |
775,122 |
|
|
$ |
872,810 |
|
GAAP gross margin (GAAP gross profit/revenue) |
|
37.7 |
% |
|
37.3 |
% |
|
38.6 |
% |
|
37.5 |
% |
|
37.6 |
% |
|||||
Non-GAAP gross margin (Non-GAAP gross profit/revenue) |
|
46.9 |
% |
|
47.0 |
% |
|
47.0 |
% |
|
47.1 |
% |
|
46.4 |
% |
Table G: Non-GAAP operating income |
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
Q3'19 |
|
Q2'19 |
|
Q3'18 |
|
Q3'19 |
|
Q3'18 |
||||||||||
GAAP operating income [i] |
|
$ |
45,225 |
|
|
$ |
13,486 |
|
|
$ |
75,081 |
|
|
$ |
90,527 |
|
|
$ |
161,688 |
|
Impact of reconciling items on cost of revenues (see Table A, B, C, D and E) |
|
52,917 |
|
|
51,258 |
|
|
56,481 |
|
|
157,514 |
|
|
166,565 |
|
|||||
Impact of reconciling items on R&D (see Table A, B, C, D and E) |
|
8,241 |
|
|
14,298 |
|
|
9,389 |
|
|
31,481 |
|
|
30,967 |
|
|||||
Impact of reconciling items on SG&A (see Table A, B, C, D and E) |
|
19,142 |
|
|
29,372 |
|
|
25,276 |
|
|
68,175 |
|
|
59,997 |
|
|||||
Non-GAAP operating income [ii] |
|
$ |
125,525 |
|
|
$ |
108,414 |
|
|
$ |
166,227 |
|
|
$ |
347,697 |
|
|
$ |
419,217 |
|
Impact of reconciling items on operating income [ii - i] |
|
$ |
80,300 |
|
|
$ |
94,928 |
|
|
$ |
91,146 |
|
|
$ |
257,170 |
|
|
$ |
257,529 |
|
GAAP operating margin (GAAP operating income / revenue) |
|
7.9 |
% |
|
2.5 |
% |
|
11.2 |
% |
|
5.5 |
% |
|
8.6 |
% |
|||||
Non-GAAP operating margin (Non-GAAP operating income / revenue) |
|
21.8 |
% |
|
20.4 |
% |
|
24.7 |
% |
|
21.1 |
% |
|
22.3 |
% |
Table H: Non-GAAP pre-tax profit |
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
Q3'19 |
|
Q2'19 |
|
Q3'18 |
|
Q3'19 |
|
Q3'18 |
||||||||||
GAAP income before income taxes and non-controlling interest ("Pre-tax income") |
|
$ |
30,303 |
|
|
$ |
1,483 |
|
|
$ |
60,022 |
|
|
$ |
54,359 |
|
|
$ |
114,332 |
|
Share in gain/loss, net and impairment of equity method investees 1 |
|
(1,383 |
) |
|
(32,405 |
) |
|
(3,657 |
) |
|
(37,378 |
) |
|
(10,873 |
) |
|||||
Impact of reconciling items on operating income (see Table G) |
|
80,300 |
|
|
94,928 |
|
|
91,146 |
|
|
257,170 |
|
|
257,529 |
|
|||||
Impact of reconciling items on interest and other expense, net (see Table A, B, C, D and E) |
|
9,231 |
|
|
35,362 |
|
|
8,045 |
|
|
48,448 |
|
|
26,065 |
|
|||||
Non-GAAP pre-tax profit |
|
$ |
118,451 |
|
|
$ |
99,368 |
|
|
$ |
155,556 |
|
|
$ |
322,599 |
|
|
$ |
387,053 |
|
GAAP pre-tax profit margin (GAAP pre-tax income/revenue) |
|
5.3 |
% |
|
0.3 |
% |
|
8.9 |
% |
|
3.3 |
% |
|
6.1 |
% |
|||||
Non-GAAP pre-tax profit margin (Non-GAAP pre-tax profit/revenue) |
|
20.6 |
% |
|
18.7 |
% |
|
23.1 |
% |
|
19.6 |
% |
|
20.6 |
% |